We are live on
!
Find out more
Kymera Therapeutics
KYMR
KYMR
164 hedge funds and large institutions have $2.7B invested in Kymera Therapeutics in 2024 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 58 increasing their positions, 45 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
268% more call options, than puts
Call options by funds: $2.73M | Put options by funds: $740K
223% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 13
74% more capital invested
Capital invested by funds: $1.55B → $2.7B (+$1.15B)
29% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 45
21% more funds holding
Funds holding: 136 → 164 (+28)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
0.28% more ownership
Funds ownership: 109.74% → 110.02% (+0.28%)
Holders
164
Holders Change
+28
Holders Change %
+20.59%
% of All Funds
2.36%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
42
Increased
58
Reduced
45
Closed
13
Calls
$2.73M
Puts
$740K
Net Calls
+$1.99M
Net Calls Change
+$453K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$137M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$45.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$35.6M |
| 4 |
State Street
Boston,
Massachusetts
|
+$27.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.5M |
